Search the Newsreel

Nuveen Multi-Asset Income Fund (NMAI) Holds Steady as Yield-Seekers Circle - Moving Average Ribbon

Earnings call transcript: Universal Insurance tops Q2 2026 forecasts, shares jump

Universal Insurance (NYSE:UVE) Shares Gap Up Following Strong Earnings

Universal Insurance Q2 Adjusted Earnings, Revenue Increase

Universal Insurance Holdings Inc. (NYSE: UVE) reported increased adjusted earnings and total revenue for the second quarter, surpassing analyst estimates. Despite the positive financial performance, the company's adjusted earnings per share saw a slight decline compared to the previous year, while total policies in …

Earnings Flash (UVE) Universal Insurance Holdings, Inc. Reports Q2 Revenue $427.0M, vs. FactSet Est of $381.6M

Universal Insurance Holdings, Inc. (UVE) reported Q2 revenue of $427.0 million, significantly exceeding FactSet's estimate of $381.6 million. The company's stock symbol is UVE, and it operates in the Property & Casualty Insurance sector, primarily in Florida. The report also indicated increased adjusted earnings …

Nuveen Churchill Direct Lending (NYSE:NCDL) Upgraded by Zacks Research to "Hold" Rating

Zacks Research has upgraded Nuveen Churchill Direct Lending (NCDL) from "strong sell" to "hold" despite the stock trending near its 52-week low. The company recently missed quarterly EPS and revenue estimates, however, insider buying activity by Treasurer Shaul Vichness and CAO Marissa Hassen indicates …

UNIVERSAL INSURANCE HLDGS ($UVE) Releases Q2 2026 Earnings, Stock Rises

UNIVERSAL INSURANCE HLDGS ($UVE) reported strong Q2 2026 earnings, exceeding analyst estimates for both earnings per share and revenue, leading to a 6.02% stock price increase. Despite insider selling activity, 96 institutional investors increased their positions in the company, highlighting mixed investor sentiment. Key …

Earnings Flash (UVE) Universal Insurance Holdings, Inc. Posts Q2 Adjusted EPS $1.84 per Share, vs. FactSet Est of $1.43

Universal Insurance Holdings, Inc. (UVE) announced its Q2 adjusted EPS of $1.84 per share, significantly exceeding the FactSet estimate of $1.43. The company also reported Q2 revenue of $427.0 million, surpassing the FactSet estimate of $381.6 million. This positive earnings flash indicates stronger-than-expected financial …

Press Release: Universal Reports Second Quarter 2026 Results

Universal has issued a press release detailing its financial results for the second quarter of 2026. The company reported its performance, indicating key financial metrics for the period.

Universal Insurance Holdings (UVE) Q2 Earnings and Revenues Beat Estimates

Universal Insurance Holdings (UVE) reported Q2 earnings of $1.84 per share, significantly surpassing the Zacks Consensus Estimate of $1.43, and revenues of $427.03 million, beating estimates by 11.91%. The company has consistently exceeded EPS and revenue estimates over the past four quarters. Despite outperforming …

Correction: Nuvectis Announces Marketing Approval of Ciprocopan in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Nuvectis Pharma, Inc. announced that its partner Haisco has received marketing approval in China for ciprocopan (NXP100), a once-daily oral Complement Factor B inhibitor, to treat patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) previously untreated with complement inhibitors. This marks the world's first approval for …

Universal Insurance faces earnings test as premium valuation looms

Universal Insurance Holdings Inc. is set to announce its second-quarter earnings, with analysts expecting $1.57 per share on $614.62 million in revenue. Despite a strong stock performance fueled by consecutive earnings beats and favorable hurricane seasons, the company faces scrutiny after a recent downgrade …

Nuvectis Drug Reached 12 g/dL in 59.5% of PNH Patients

Nuvectis Pharma announced that its once-daily oral Complement Factor B inhibitor, ciprocopan (NXP100), has received marketing approval in China for treating Paroxysmal Nocturnal Hemoglobinuria (PNH) patients previously untreated with complement inhibitors. This marks the first global approval for such a drug and is based …

Ciprocopan (NXP100) Receives Marketing Approval in China

Nuvectis Pharma, Inc. announced that its drug ciprocopan (NXP100), a once-daily oral complement Factor B inhibitor, has received marketing approval in China for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) untrained with complement inhibitors. This approval marks the world's first for such a drug, providing …

UVE|Universal Insurance Holdings Inc|Price:42.380|Chg%:+0.140

Universal Insurance (NYSE:UVE) Posts Earnings Results, Beats Expectations By $0.22 EPS

Nouveau Monde Graphite Inc. (NMG) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Nouveau Monde Graphite Inc. (NMG), including its current stock price, recent news, historical data, and financial performance. It details the company's operations in graphite exploration and development in Quebec, Canada, and offers analyst insights and …

What's Going On With Nouveau Monde Graphite Inc Stock Wednesday?

Nuveen Churchill Direct Lending Corp. (NYSE:NCDL) Given Consensus Recommendation of "Reduce" by Analysts

Nuveen Churchill Direct Lending Corp. (NYSE:NCDL) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $14.44. The company recently reported mixed quarterly results, missing EPS expectations by a small margin but significantly missing revenue estimates. Despite these results, …

Universal Insurance Holdings (UVE) Shares Retreat 2% as Resistance Holds - Rating Change

Universal Insurance Holdings Inc expected to post earnings of $1.62 a share - Earnings Preview

Universal Insurance Holdings Inc is projected to report earnings of $1.62 per share. This information comes from an earnings preview. The article, sourced from Reuters, suggests a more detailed analysis requires a free trial to read further.

Earnings Preview: UVE to Report Financial Results Post-market on July 24

This article is a placeholder indicating that Universal Insurance Holdings (UVE) is scheduled to release its financial results on July 24, after market close. It suggests that investors will be looking for key metrics like EPS and revenue, though specific analyst expectations are not …

Liquidity Mapping Around (NPCT) Price Events

The article provides an AI-generated analysis of Nuveen Core Plus Impact Fund (NPCT), highlighting a neutral sentiment and a mid-channel oscillation pattern. It outlines three institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels, and details multi-timeframe signal …

(NMAI) Movement Within Algorithmic Entry Frameworks

This article analyzes Nuveen Multi-asset Income Fund Of Beneficial Interest (NMAI) using AI models, identifying neutral near and mid-term readings but a positive long-term bias. It outlines three distinct trading strategies for NMAI—Position, Momentum Breakout, and Risk Hedging—along with their respective entry, target, and …

Clinuvel Pharmaceuticals (ASX:CUV) Shares Closed Higher Today- What Are Healthcare Investors Watching?

Nouveau Monde Graphite Inc. (NYSE:NMG) Given Average Recommendation of "Buy" by Brokerages

Seven brokerages have issued a consensus recommendation of "Buy" for Nouveau Monde Graphite Inc. (NYSE:NMG), with an average 12-month price target of $4.67. The stock is currently trading near its 52-week low of $1.37, despite recently beating quarterly earnings expectations. Analysts anticipate the company …

Nuveen Churchill Direct Lending Corp. (NYSE:NCDL) Short Interest Update

Nuveen Churchill Direct Lending Corp. sets Q2 2026 earnings date

Nuveen Churchill Direct Lending Corp. announced it will release its Q2 2026 financial results on August 6, 2026, before market open. The company will host an earnings conference call and webcast at 10:00 AM ET on the same day to discuss the results. Nuveen …

Nuveen Churchill Direct Lending Corp. Schedules Second Quarter 2026 Earnings Release and Conference Call

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) announced it will report its second quarter 2026 financial results on Thursday, August 6, 2026, before market open. The company will host an earnings conference call and webcast at 10:00 AM ET on the same day to …

Universal Insurance (UVE) to Announce Quarterly Earnings on Thursday

Piper Sandler Downgrades Universal Insurance Holdings Inc(UVE.US) to Hold Rating, Raises Target Price to $44

Piper Sandler has downgraded Universal Insurance Holdings Inc (UVE.US) to a Hold rating from an Overweight rating. Despite the downgrade, the firm increased its target price for UVE to $44.

Nuveen Churchill to Report Q2 Results Before Markets Open

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) announced it will report its second-quarter 2026 financial results on Thursday, August 6, 2026, before the market opens. The company will also host an earnings conference call and webcast at 10:00 AM ET on the same day …

Universal Insurance Holdings Down Over 9%, on Pace for Largest Percent Decrease Since October 2024 -- Data Talk

Universal Insurance Holdings (UVE) experienced a significant drop of over 9% in its stock price, placing it on track for its largest single-day percentage decrease since October 2024. The stock reached an intraday low of $15.54 and is now trading around a 23% increase …

Universal Insurance Holdings sets Q2FY26 earnings release date

Universal Insurance Holdings, Inc. announced it will release its second quarter 2026 earnings after market close on July 23, 2026. A conference call is scheduled for July 24, 2026, at 10:00 a.m. ET to discuss the financial results and operational metrics, covering personal residential …

Nuveen Multi-Asset Income Fund (NMAI) Gains Ground as Yield-Seeking Investors Return - Wave Equality

Clinuvel Pharmaceuticals Moves as Its Global Rare-Disease Opportunity Attracts Fresh Attention